Bioprospecting of thraustochytrids for omega-3 fatty acids: A sustainable approach to reduce dependency on animal sources
Abstract
Abstract Backgrounds Omega-3 and omega-6 fatty acids are examples of polyunsaturated fatty acids (PUFAs). The omega-3 α-linolenic acid and omega-6 linoleic acid cannot be generated by humans and, therefore, are considered essential fatty acids. Long-chain PUFAs, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), can be produced from α-linolenic acid in the human body, but at a level too low to meet daily requirements and must be supplemented through the diet. Daily intake of EPA and DHA reduces the risk of heart disease, Alzheimer's, bipolar disorder, schizophrenia, and type 2 diabetes; moreover, DHA is essential for proper visual and neurological postnatal development. Scope and approach Fish oil and seafood are widely used as sources of omega fatty acids, which represents a two-fold problem. First, it depletes fish stocks and impacts negatively on the aquatic environment through excessive aquaculture. Second, the growing popularity of veganism and vegetarianism puts these consumers at risk of omega-3 fatty acid deficiency. Hence, alternative sources of long-chain PUFAs for human consumption should be found. Plants produce only a handful of PUFAs, such as linoleic acid, α-linolenic acid, γ-linolenic acid, and octadecatetraenoic acid. Key findings and conclusions Thraustochytrids, non-photosynthetic marine microorganisms often mislabeled as ‘algae’, represent a promising commercial source of omega-3 fatty acids due to their high content of PUFAs. In this…
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.